The Interventional Neurology Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Interventional Neurology Market is estimated to be $ 1896.08 Million in 2016 and predicted to rise to $ 2898.67 Million by the end of 2021 with a CAGR of 8.86 %. The Market is categorized based on Technology, the market is categorized into embolization and coiling, balloon angioplasty, carotid stenting, neurothrombectomy, micro support devices and others. Based on Product the market is categorized into carotid Stent, microcatheter, flow diversion, microguidewires, suction device, stenting systems, clot retrieval and others. Based on end users, the market is segmented into hospitals, ambulatory centers, neurology clinics and others. Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The market is primarily driven by factors such as growth in patient population, advancements in technology, favourable reimbursements across mature markets, and increasing healthcare infrastructure across the developing countries. Ongoing healthcare reforms in United States, lack of skilled neurosurgeons, stringent regulatory bodies across major markets are the restraints that are hindering the growth of the Infectious disease therapeutics market.
Based on Technology, the embolization & coiling technology segment is expected to account the largest market share, while the Balloon Angioplasty segment is predicted to be the fastest growing segment. High growth of Balloon Angioplasty segment is due to the expansion and adoption of balloon catheter and carotid stents among neurologists, growth in the population of patients suffering from atherosclerosis and ischemic strokes, increasing neurologists, hospitals and neurosurgical centers.
North America is expected to account the largest market share in the market, followed by Europe. Asia Pacific is predicted to show the highest CAGR during the forecast period, due to increasing awareness among neurologists related to the benefits of an interventional neurology devices and reducing prices of neurovascular devices in Asia Pacific. North America market is expected to have highest share owing to favourable reimbursement scenario and large presence of device manufacturers in the region.
Major players that are influencing Global Interventional Neurology Market areStryker Corporation, Medtronic plc, Johnson & Johnson, Terumo Corporation, Penumbra Inc., Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates Inc., Microport Scientific Corporation, and Medikit Co., Ltd.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-interventional-neurology-devices-market-1711/” and checkout our recent reports in the Medical Devices category at “http://www.marketdataforecast.com/research-reports/healthcare/medical-devices-2/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.